Big Pharma is currently failing to reach huge markets in countries on Levels 2 and 3, where hundreds of millions of people, like the diabetes patient we met in Kerala, need drugs that have already been discovered, but at more reasonable prices. If the pharmaceutical companies were better at adjusting their prices for different countries and different customers, they could make their next fortune with what they already have.
Don't know how this works but interesting theory.
